45 virtualization-"https:"-"https:"-"https:" Fellowship positions at Center for Drug Evaluation and Research (CDER)

FDA Biomarker Qualification Fellowship

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 8 days ago

of liver injury cases using clinical trial data. Learning Objectives: Under the guidance of a mentor, You will learn about regulatory science, clinical trial design, and safety analysis. You will collaborate

FDA Application of AI for Precision Medicine Fellowship

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 8 days ago

(qi.liu@fda.hhs.gov ). If you have questions about the nature of the research, please contact the mentor. Anticipated Appointment Start Date: 2026. Start date is flexible and will depend on a variety of

FDA CDER Regulatory Science Fellowship

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 8 days ago

for novel drug applications Gain understanding of data pipelines used for dashboard development. Mentor: The mentor for this opportunity is Mary Doi (mary.doi@fda.hhs.gov ). If you have questions about the

FDA Pharmacy Compounding Regulatory Analysis Fellowship

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 8 days ago

for this opportunity is Kemi Asante (kemi.asante@fda.hhs.gov ). If you have questions about the nature of the research, please contact the mentor. Anticipated Appointment Start Date: September 2026. Start date is

FDA Large Language Models (LLM) for Case Definition Classification Fellowship

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 8 days ago

Dang (Oanh.Dang@fda.hhs.gov ). If you have questions about the nature of the research, please contact the mentors. Anticipated Appointment Start Date: 2026. Start date is flexible and will depend on a

FDA Developmental Safety Fellowship

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 8 days ago

development have been restricted to juvenile animal studies for the past 20 years. The FDA program to reduce, refine and replace animal studies has stimulated an important discussion about both increasing

FDA Fellowship - AI to Evaluate Maximum Daily Dose for Topical Drugs

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 8 days ago

: The mentor for this opportunity is Hon Sum Ko (HonSum.Ko@fda.hhs.gov ). If you have questions about the nature of the research, please contact the mentor. Anticipated Appointment Start Date: June 2026. Start

FDA Fellowship - Enhancing Oncology Dose Optimization Through Patient-Reported Outcome Exposure-Response Analysis

Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | 8 days ago

: The mentor for this opportunity is Jeanne Fourie Zirkelbach, PhD (Jeanne.fouriezirkelbach@fda.hhs.gov ). If you have questions about the nature of the research, please contact the mentor. Anticipated

FDA Fellowship - Statistical Methods for Three-Arm Clinical Trials with Multiple Testing Procedure

Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | about 1 month ago

group. The conventional Dunnett’s type I error rate adjustment proposed in 1955 is for superiority tests with normally distributed data. There are statistical concerns about generalizing the procedure

FDA Fellowship - Clinical Pharmacology Considerations for Novel Therapeutic Modalities

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 8 days ago

. Mentor: The mentors for this opportunity are Qin Sun (Qin.Sun@fda.hhs.gov ) and Yow-Ming Wang (Yowming.Wang@fda.hhs.gov ). If you have questions about the nature of the research, please contact the mentors